NCT02143778View on ClinicalTrials.gov

Assessing Portal Hypertension With Methacetin Breath Test

NACompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

January 31, 2019

Conditions
Patients With Compensated Liver Cirrhosis
Interventions
DEVICE

Methacetin Breath Test

13C labelled methacetin solution for breath test monitoring

Trial Locations (8)

3010

Inselspital, Bern

23298

Virginia Commonwealth University, Richmond

27710

Duke University Medical Center, Durham

06516

VA Connecticut HealthCare System, New Haven

Unknown

Hôpital Beaujon, Paris

Hopital Purpan, Toulouse

(University of Barcelona) Hospital Clinic, Barcelona

Hospital Universitario Ramón y Cajal, Madrid

Sponsors
All Listed Sponsors
lead

Meridian Bioscience, Inc.

INDUSTRY